Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vijay Kumar Chopra"'
Autor:
Jagdish Chander Mohan, Jamshed Dalal, Vijay Kumar Chopra, Calambur Narasimhan, Prafulla Kerkar, Abraham Oomman, Saumitra Ray Fcsi, Anshu Rajnish Sharma, Pankaj Dougall, Shelley Simon, Atul Verma Drm, Vivek Radhakrishnan
Publikováno v:
Indian Heart Journal, Vol 74, Iss 6, Pp 441-449 (2022)
Transthyretin cardiac amyloidosis (ATTR-CM) is a rare and under-recognized disorder characterized by the aggregation of transthyretin-derived insoluble amyloid fibrils in the myocardium. Heterogeneity of symptoms at presentation, makes its diagnosis
Externí odkaz:
https://doaj.org/article/6c32440f26914cd3abf3eb45ca5a66ef
Publikováno v:
Applied Medical Informatics, Vol 43, Iss 2, Pp 81-90 (2021)
Purpose: The rising prevalence of heart failure (HF) in midlife years in Indians is posing an economic challenge. Sacubitril/valsartan demonstrated a significant risk reduction of cardiovascular deaths by 20% and HF rehospitalizations by 21% versus e
Externí odkaz:
https://doaj.org/article/688f64eeb2cc4345a2cd7e07be6e7ea3
Publikováno v:
Journal of the Practice of Cardiovascular Sciences, Vol 4, Iss 3, Pp 211-213 (2018)
Introduction: The patient care workshop was organized by the heart failure (HF) association of the European Society of Cardiology (ESC) in Vilnius, Lithuania on October 26, 2018. Cardiologists, general practitioners, and nurses from nine countries we
Externí odkaz:
https://doaj.org/article/c81db9edae8242c0af062f1c8b5d0c50
Autor:
Vijay Kumar Chopra, Soumitra Kumar, Arup Dasbiswas, Devang Desai, Debanu Ghoshroy, Jagdish Chander Mohan, Srinivasa Rao Maddury
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 4, Pp OE01-OE07 (2018)
Heart Failure (HF) in chronic setting is an important cardiac cause of morbidity and mortality. HF burden in India is expected to increase because of increasing risk factors especially hypertension and Coronary Artery Disease (CAD). Treatment of HF i
Externí odkaz:
https://doaj.org/article/fab1f5ae52424264bef2ae1618c08e00
Autor:
Jamshed Dalal, Murugesh Shantaveeraya Hiremath, Mrinal Kanti Das, Devangkumar M Desai, Vijay Kumar Chopra, Arup Das Biswas
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 9, Pp OE08-OE12 (2016)
Coronary Artery Disease (CAD) occurs at a younger age in Indians with over 50% of Cardiovascular Disease (CVD) mortality occurring in individuals aged less than 50 years. Although several risk factors have been suggested; smoking, dyslipidemia and h
Externí odkaz:
https://doaj.org/article/b50e43ad42c6462f88a0b2f9447a00ed
Autor:
Debanu Ghoshroy, Vijay Kumar Chopra, Jagdish C. Mohan, Soumitra Kumar, Srinivasa Rao Maddury, Devang Desai, Arup Dasbiswas
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 4, Pp OE01-OE07 (2018)
Heart Failure (HF) in chronic setting is an important cardiac cause of morbidity and mortality. HF burden in India is expected to increase because of increasing risk factors especially hypertension and Coronary Artery Disease (CAD). Treatment of HF i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda01c6218c033db8074e215e1c0b706
https://doi.org/10.7860/jcdr/2018/31278.11346
https://doi.org/10.7860/jcdr/2018/31278.11346
Autor:
Anthony C. Keech, Peter Sever, Lixin Jiang, Atsushi Hirayama, Chen Lu, Leslie Tay, Prakash Deedwania, Chung-Wah Siu, Armando Lira Pineda, Donghoon Choi, Min-Ji Charng, John Amerena, Wan Azman Wan Ahmad, Vijay Kumar Chopra, Terje Pedersen, Robert Giugliano, Marc Sabatine
Publikováno v:
Journal of the American College of Cardiology. 73:189
There are concerns that Asian people respond differently to some medications. We evaluated the efficacy and safety of evolocumab use in the FOURIER trial among participants of Asian versus other backgrounds. The effects of adding evolocumab (either 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0088e5dc501bc14616b20f55c98c82f
https://doi.org/10.1016/s0735-1097(19)30797-1
https://doi.org/10.1016/s0735-1097(19)30797-1
Autor:
Vijay Kumar Chopra
Publikováno v:
The Journal of Investing. 2:51-59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85b506203a45bd12e356c38d2b75b95a
https://doi.org/10.3905/joi.2.3.51
https://doi.org/10.3905/joi.2.3.51